PROBE: patient and physician behaviour and education in prostate disease
First published: 18 December 2007
No abstract is available for this article.
References
- 1
Emberton M,
Marberger M,
De La Rosette J.
Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: The Prostate Research on Behaviour and Education (PROBE) Survey.
Int J Clin Pract
2008; 62: 18–26.
- 2
McConnell JD,
Bruskewitz R,
Walsh P
et al.
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with BPH. Finasteride Long-term Efficacy and Safety Study Group.
N Engl J Med
1998; 338: 557–563.
- 3
McConnell JD,
Roehrborn CG,
Bautista OM
et al.
The long-term effect of doxazosin, finasteride and combination therapy on the clinical progression of benign prostatic hyperplasia.
N Engl J Med
2003; 349: 2387–2398.
- 4
Brown CT,
Yap T,
Cromwell DA
et al.
Self management for men with lower urinary tract symptoms: randomised controlled trial.
BMJ
2007; 334: 25–28.
- 5
Te AE.
Current state of the art photoselective vaporization prostatectomy: laser therapy for benign prostatic hyperplasia.
Prostate Cancer Prostate Dis
2007; 10 (Suppl. 1): S2–S5.
- 6
Rosenberg MT,
Staskin DR,
Kaplan SA
et al.
A practical guide to the evaluation and treatment of male urinary tract symptoms in the primary care setting.
Int J Clin Pract
2007; 61: 1535–46.
- 7
Naslund MJ,
Glisenan AW,
Midkiff KD
et al.
Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting.
Int J Clin Pract
2007; 61: 1437–45.
